Zihao Hua, Ph.D. - Publications

2004 Stony Brook University, Stony Brook, NY, United States 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Liu L, Lee MR, Kim JL, Whittington DA, Bregman H, Hua Z, Lewis RT, Martin MW, Nishimura N, Potashman M, Yang K, Yi S, Vaida KR, Epstein LF, Babij C, et al. Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling. Bioorganic & Medicinal Chemistry. PMID 27085672 DOI: 10.1016/j.bmc.2016.03.055  0.96
2014 Epstein O, Bryan MC, Cheng AC, Derakhchan K, Dineen TA, Hickman D, Hua Z, Human JB, Kreiman C, Marx IE, Weiss MM, Wahl RC, Wen PH, Whittington DA, Wood S, et al. Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors. Journal of Medicinal Chemistry. 57: 9796-810. PMID 25389560 DOI: 10.1021/Jm501266W  0.96
2013 Hua Z, Bregman H, Buchanan JL, Chakka N, Guzman-Perez A, Gunaydin H, Huang X, Gu Y, Berry V, Liu J, Teffera Y, Huang L, Egge B, Emkey R, Mullady EL, et al. Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors. Journal of Medicinal Chemistry. 56: 10003-15. PMID 24294969 DOI: 10.1021/Jm401317Z  0.96
2012 Huang H, Acquaviva L, Berry V, Bregman H, Chakka N, O'Connor A, DiMauro EF, Dovey J, Epstein O, Grubinska B, Goldstein J, Gunaydin H, Hua Z, Huang X, Huang L, et al. Structure-Based Design of Potent and Selective CK1γ Inhibitors. Acs Medicinal Chemistry Letters. 3: 1059-64. PMID 24900428 DOI: 10.1021/Ml300278F  0.96
2012 Hua Z, Huang X, Bregman H, Chakka N, DiMauro EF, Doherty EM, Goldstein J, Gunaydin H, Huang H, Mercede S, Newcomb J, Patel VF, Turci SM, Yan J, Wilson C, et al. 2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22: 5392-5. PMID 22877629 DOI: 10.1016/J.Bmcl.2012.07.046  0.96
2006 Chapsal BD, Hua Z, Ojima I. Catalytic asymmetric transformations with fine-tunable biphenol-based monodentate ligands Tetrahedron Asymmetry. 17: 642-657. DOI: 10.1016/J.Tetasy.2005.12.035  0.96
2004 Choi H, Hua Z, Ojima I. Highly enantioselective copper-catalyzed conjugate addition of diethylzinc to nitroalkenes. Organic Letters. 6: 2689-91. PMID 15281745 DOI: 10.1021/Ol0491282  0.96
2004 Hua Z, Vassar VC, Choi H, Ojima I. New biphenol-based, fine-tunable monodentate phosphoramidite ligands for catalytic asymmetric transformations. Proceedings of the National Academy of Sciences of the United States of America. 101: 5411-6. PMID 15020764 DOI: 10.1073/Pnas.0307101101  0.96
2003 Hua Z, Vassar VC, Ojima I. Synthesis of new chiral monodentate phosphite ligands and their use in catalytic asymmetric hydrogenation. Organic Letters. 5: 3831-4. PMID 14535721 DOI: 10.1021/Ol035343R  0.96
2001 Bonafoux D, Hua Z, Wang B, Ojima I. Design and synthesis of new fluorinated ligands for the rhodium-catalyzed hydroformylation of alkenes in supercritical CO2 and fluorous solvents Journal of Fluorine Chemistry. 112: 101-108. DOI: 10.1016/S0022-1139(01)00473-0  0.96
Show low-probability matches.